News for CASI Pharmaceuticals, Inc. (CASI)

**media[552077]**

BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development and commer

CASI Pharmaceuticals Inc. (CASI) experienced a significant stock price drop of 6.33%, trading at $5.77 per share with a volume of 6,320 shares. This represents

Stay up to date on Casi Pharmaceuticals (CASI) with the latest offer and sale filings.

Read about CASI Pharmaceuticals' second quarter 2024 financial results with a GAAP EPS of -$0.52 and revenue of $3.98M, a YoY decrease of 59.5%.

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.

China-based CASI Pharmaceuticals, Inc. (CASI), a biopharmaceutical company is up over 43 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

CASI Pharmaceuticals (CASI) surged in extended trading on Wednesday after the company said it has received a preliminary non-binding proposal letter from CEO We

Casi Pharmaceuticals (CASI) stock gains as company receives FDA clearance to run a clinical study for its thrombocytopenia drug, CID-103. Read more here.

California-based NKGen Biotech, Inc. (NKGN), a clinical-stage biotechnology company is up over 59% in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Feb 23, 2022 / 01:00PM GMTMartin Welschof - BioInvent International AB(publ)-CEO Thank you very much, and welcome, everybody, to our quarterly call. And I would

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER ...

Gainers

The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw Companies.

Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf...

During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the ...